Lavipharm SA LAVI-GR:Athens Stock Exchange

*Data is delayed | Exchange | EUR
Last | 5:13 PM EEST
0.85quote price arrow down-0.003 (-0.35%)
Volume
87,588
52 week range
0.76 - 0.96
Loading...
  • Open0.85
  • Day High0.87
  • Day Low0.84
  • Prev Close0.85
  • 52 Week High0.96
  • 52 Week High Date02/23/24
  • 52 Week Low0.76
  • 52 Week Low Date01/23/24

Key Stats

  • Market Cap153.56M
  • Shares Out167.87M
  • 10 Day Average Volume77,542
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change6.78

KEY STATS

  • Open0.85
  • Day High0.87
  • Day Low0.84
  • Prev Close0.85
  • 52 Week High0.96
  • 52 Week High Date02/23/24
  • 52 Week Low0.76
  • 52 Week Low Date01/23/24
  • Market Cap153.56M
  • Shares Out167.87M
  • 10 Day Average Volume77,542
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change6.78

RATIOS/PROFITABILITY

  • EPS (TTM)0.01
  • P/E (TTM)85.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lavipharm SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm...
Minas Tanes
Chairman of the Board
Venetsiana-Loukia Lavida
Vice President of the Board of Directors
Panagiotis Giannouleas
Chief Operations Officer, Country Manager
Vassilis Baloumis
Chief Financial Officer, Head - Investor Relations
Address
Agias Marinas Street, Peania
PO Box 59
Athina
190 02
Greece